On Tuesday, Artelo Biosciences Inc (NASDAQ: ARTL) was -7.11% drop from the session before settling in for the closing price of $2.11. A 52-week range for ARTL has been $1.66 – $28.60.
During the last 5-year period, the sales growth of Healthcare Sector giant was 27.29%. When this article was written, the company’s average yearly earnings per share was at 60.16%. With a float of $1.14 million, this company’s outstanding shares have now reached $1.15 million.
Let’s determine the extent of company efficiency that accounts for 6 employees.
Artelo Biosciences Inc (ARTL) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Artelo Biosciences Inc stocks. The insider ownership of Artelo Biosciences Inc is 0.61%, while institutional ownership is 2.71%.
Artelo Biosciences Inc (ARTL) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -2.1 earnings per share (EPS) during the time that was better than consensus figure (set at -10.68) by 8.58.
According to the Wall Street analysts, stocks earnings will be around 60.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 68.35% during the next five years compared to 27.29% growth over the previous five years of trading.
Artelo Biosciences Inc (NASDAQ: ARTL) Trading Performance Indicators
You can see what Artelo Biosciences Inc (ARTL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -19.05, a number that is poised to hit -0.82 in the next quarter and is forecasted to reach -0.74 in one year’s time.
Technical Analysis of Artelo Biosciences Inc (ARTL)
Looking closely at Artelo Biosciences Inc (NASDAQ: ARTL), its last 5-days average volume was 0.7 million, which is a jump from its year-to-date volume of 0.28 million. As of the previous 9 days, the stock’s Stochastic %D was 21.44%.
During the past 100 days, Artelo Biosciences Inc’s (ARTL) raw stochastic average was set at 1.11%, which indicates a significant decrease from 14.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.33 in the past 14 days, which was lower than the 1.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.29, while its 200-day Moving Average is $7.16. However, in the short run, Artelo Biosciences Inc’s stock first resistance to watch stands at $2.13. Second resistance stands at $2.31. The third major resistance level sits at $2.47. If the price goes on to break the first support level at $1.79, it is likely to go to the next support level at $1.63. Now, if the price goes above the second support level, the third support stands at $1.45.
Artelo Biosciences Inc (NASDAQ: ARTL) Key Stats
There are 704K outstanding shares of the company, which has a market capitalization of 2.25 million. As of now, sales total 0 K while income totals -9,830 K. Its latest quarter income was 0 K while its last quarter net income were -3,220 K.
